Jorge Silvio Gutkind

45PUBLICATIONS
301CO-AUTHORS
Molecular targetsCell development, proliferation and deathPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jul 28, 2026
A Phase II Trial of Defactinib Combined with Avutometinib in Patients with Metastatic Uveal Melanoma.

|Jul 10, 2026
Selective knockout of PKA regulatory subunits reveal opposite catalytic and metabolic consequences with implications for Alzheimer's disease.

|Jun 30, 2026
Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model.

|Feb 06, 2026
Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses.

Kanika Dhawan, Michael M Allevato, Jacqueline Lesperance

|Jan 12, 2026
Aberrant Hippo-YAP/TEAD Signaling Drives Malignant Transcriptional Reprogramming in External Auditory Canal Squamous Cell Carcinoma.

Kuniaki Sato, Noritaka Komune, Mayumi Ono

|Jan 10, 2026
Unraveling Resistance Mechanisms to Gαq Pathway Inhibition in Uveal Melanoma: Insights from Signaling-Activation Library Screening.

Simone Lubrano, Rodolfo Daniel Cervantes-Villagrana, Nadia Arang

Pageof 8

Frequent Collaborators

8 joint publications

Kuniaki Sato

6 joint publications

Nadia Arang

5 joint publications

Alfredo A Molinolo

5 joint publications

Robert Saddawi-Konefka